Veracyte (VCYT) Capital Leases (2016 - 2018)
Veracyte (VCYT) posted Capital Leases of $79000.0 for Q3 2018, down 49.36% sequentially from $156000.0 in Q2 2018, and down 79.32% YoY from $382000.0 in Q3 2017.
Veracyte (VCYT) Capital Leases (2016 - 2018) Analysis & Trends
Veracyte (VCYT) has 3 years of Capital Leases data on file, last reported at $79000.0 in Q3 2018.
- Quarterly Capital Leases fell 79.32% year-over-year to $79000.0 in Q3 2018, while the trailing twelve-month figure through Sep 2018 was $79000.0 (down 79.32% YoY) and the FY2017 annual result came in at $308000.0, down 48.58% from the prior year.
- Capital Leases slipped to $79000.0 in Q3 2018 per VCYT's latest filing, from $156000.0 in the prior quarter.
- The five-year high for Capital Leases was $599000.0 in Q4 2016, with the low at $79000.0 in Q3 2018.
- Average Capital Leases over 3 years is $342625.0, with a median of $345000.0 recorded in 2017.
- Year-over-year, Capital Leases plunged 48.58% in 2017 and plunged 79.32% in 2018.
- Veracyte's Capital Leases stood at $599000.0 in 2016, then plunged by 48.58% to $308000.0 in 2017, then slumped by 74.35% to $79000.0 in 2018.
- Business Quant data shows VCYT's Capital Leases at $79000.0 in Q3 2018, $156000.0 in Q2 2018, and $233000.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | Veracyte | 4.76 Bn | 4.50 Bn | 101.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2018 | 79,000.00 |
| Jun 30, 2018 | 156,000.00 |
| Mar 31, 2018 | 233,000.00 |
| Dec 31, 2017 | 308,000.00 |
| Sep 30, 2017 | 382,000.00 |
| Jun 30, 2017 | 456,000.00 |
| Mar 31, 2017 | 528,000.00 |
| Dec 31, 2016 | 599,000.00 |